Tabla 6: Sensibilidad a infecciones comunitarias y nosocomiales.

 

Origen

p

Comunitario

n (%)

Nosocomial

n (%)

Amikacina

69 (89.9)

113 (73.5)

0.022

Aztreonam

35(34.3)

32 (34.4)

0.994

Cefepima

69 (52.2)

120 (56.7)

0.430

Ceftazidima

22 (59.1)

56 (58.9)

0.787

Ceftriaxona

61(41.0)

86 (40.7)

0.334

Ertapenem

54 (96.3)

54 (92.6)

0.401

Meropenem

68 (91.2)

112 (65.2)

< 0.001

Piperacilina/tazobactam

46 (71.7)

60 (51.7)

0.073

Colistina

23 (100.0)

64 (87.5)

0.075

Ciprofloxacino

95 (46.3)

181 (44.8)

0.742

Gentamicina

91 (67.0)

176 (54.0)

0.036

Fosfomicina

28 (64.3)

73 (68.5)

0.906

Trimetroprim/sulfametoxazol

71 (46.5)

108 (54.6)

0.556

Tigeciclina

79 (81.0)

133 (74.4)

0.543

Ceftolozano/tazobactam

13 (84.6)

32 (81.3)

0.286

Ceftazidima/avibactam

20 (90.0)

63 (81.0)

0.539

Ceftarolina

9 (22.2)

35 (40.0)

0.406

Clindamicina

17 (47.1)

42 (11.9)

0.012

Levofloxacino

35 (57.1)

67 (37.3)

0.154

Moxifloxacino

24 (62.5)

54 (38.9)

0.142

Linezolid

32 (100.0)

60 (91.7)

0.244

Oxacilina

11 (72.7)

41 (14.6)

< 0.001

Rifampicina

13 (100.0)

39 (82.1)

0.260

Tetraciclina

32 (50.0)

64 (59.4)

0.383

Vancomicina

32 (96.9)

62 (100.0)

0.162

Daptomicina

5 (100.0)

8 (100.0)

0.000

Doxiciclina

3 (66.7)

12 (83.3)

0.519